Bank of Montreal’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-13,556
Closed -$456K 4076
2022
Q1
$456K Buy
13,556
+283
+2% +$9.11K ﹤0.01% 2911
2021
Q4
$458K Sell
13,273
-3,356
-20% -$109K ﹤0.01% 2457
2021
Q3
$528K Sell
16,629
-560
-3% -$19K ﹤0.01% 2848
2021
Q2
$637K Buy
17,189
+12,016
+232% +$497K ﹤0.01% 2707
2021
Q1
$222K Sell
5,173
-6,016
-54% -$282K ﹤0.01% 3062
2020
Q4
$536K Buy
11,189
+5,194
+87% +$216K ﹤0.01% 2660
2020
Q3
$219K Sell
5,995
-1,550
-21% -$49.5K ﹤0.01% 2700
2020
Q2
$216K Buy
7,545
+5,371
+247% +$155K ﹤0.01% 2690
2020
Q1
$53K Sell
2,174
-10,006
-82% -$299K ﹤0.01% 2868
2019
Q4
$410K Buy
12,180
+5,378
+79% +$195K ﹤0.01% 2779
2019
Q3
$254K Buy
6,802
+1
+0% +$38 ﹤0.01% 2763
2019
Q2
$297K Buy
6,801
+3,858
+131% +$165K ﹤0.01% 2712
2019
Q1
$126K Sell
2,943
-705
-19% -$31.6K ﹤0.01% 2956
2018
Q4
$164K Buy
3,648
+768
+27% +$40.2K ﹤0.01% 2684
2018
Q3
$197K Buy
2,880
+480
+20% +$30.9K ﹤0.01% 2763
2018
Q2
$137K Sell
2,400
-182
-7% -$9.62K ﹤0.01% 2972
2018
Q1
$119K Sell
2,582
-5
-0.2% -$237 ﹤0.01% 2876
2017
Q4
$119K Sell
2,587
-50
-2% -$2.3K ﹤0.01% 2934
2017
Q3
$119K Sell
2,637
-1,045
-28% -$44.6K ﹤0.01% 2910
2017
Q2
$145K Sell
3,682
-3,780
-51% -$143K ﹤0.01% 2811
2017
Q1
$283K Sell
7,462
-2,992
-29% -$117K ﹤0.01% 2313
2016
Q4
$388K Buy
10,454
+1,846
+21% +$66K ﹤0.01% 2213
2016
Q3
$298K Buy
8,608
+338
+4% +$11.8K ﹤0.01% 2288
2016
Q2
$268K Sell
8,270
-2,754
-25% -$84.4K ﹤0.01% 2334
2016
Q1
$318K Buy
11,024
+1,363
+14% +$36.3K ﹤0.01% 2233
2015
Q4
$323K Buy
9,661
+1,220
+14% +$37.9K ﹤0.01% 2176
2015
Q3
$241K Sell
8,441
-1,053
-11% -$36.7K ﹤0.01% 2172
2015
Q2
$384K Sell
9,494
-19,882
-68% -$892K ﹤0.01% 2101
2015
Q1
$1.45M Buy
+29,376
New +$1.36M ﹤0.01% 1486

Other funds holding AVNS

Bank of Montreal's AVNS Position: Q2 2022 in Review

Bank of Montreal sold out of Avanos Medical (AVNS) in Q2 2022, closing a stake of 13,556 shares — an estimated $456K sold.

Bank of Montreal first reported a position in AVNS in Q1 2015 and held it in 29 quarters. The position peaked at $1.45M in Q1 2015. 287 funds tracked by Wall St. Rank hold AVNS as of Q2 2022.

  • Bank of Montreal reported no remaining Avanos Medical position as of Q2 2022 after selling out during the quarter.
  • Bank of Montreal sold 13,556 Avanos Medical shares in Q2 2022, an estimated $456K.
  • Bank of Montreal first reported a position in Avanos Medical in Q1 2015 and held it in 29 quarters.
  • Bank of Montreal's Avanos Medical position peaked at $1.45M in Q1 2015.
  • 287 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2022.

Based on Bank of Montreal's 13F filing for Q2 2022, filed 11 Aug 2022.